Milestone Pharmaceuticals Inc. (MIST)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-13) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-20) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-14) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-K/A | FY-2022 | |||
| 10-K | FY-2023 | 8-K (2024-03-21) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-13) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-10) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Loss | ||
| Condensed Consolidated Statements of Shareholders' (deficit) Equity | — |
|
| Consolidated Statements of Shareholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accounts Payable and Accrued Liabilities | ||
| Accrued Liabilities | — |
|
| Commitments | — |
|
| Currency Risk | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Fair Value of Financial Instruments | ||
| Government Assistance | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventory | ||
| Leases | — |
|
| Net Loss Per Share | ||
| Organization and Nature of Operations | ||
| Other Receivables | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment | — |
|
| Revenue | ||
| Royalty Financing Obligation | — |
|
| Royalty Purchase Agreement | ||
| Segment Reporting | ||
| Share Based Compensation | ||
| Share-based Compensation | ||
| Shareholders' (deficit) Equity | — |
|
| Shareholders' Equity | ||
| Short-term Investments | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||